Strattera (atomoxetine) is a moderately effective ADHD medication, but it works noticeably less powerfully than stimulants like Adderall or Vyvanse. Its effect size in children is about 0.63 and in adults about 0.45, compared to roughly 1.0 for methylphenidate (Ritalin, Concerta) and 1.5 for lisdexamfetamine (Vyvanse). That gap is significant. Still, Strattera clearly outperforms placebo in every major clinical trial, and it has distinct advantages that make it the right choice for certain people.
How It Compares to Stimulants
Effect size is the standard way researchers measure how well a treatment works. Anything above 0.5 is considered a medium effect, and above 0.8 is large. Stimulant medications for ADHD produce unusually large effects, often between 0.9 and 1.5, which is exceptional for any psychiatric medication. Strattera lands in the moderate range. That means the average person on Strattera will see meaningful symptom improvement, but it likely won’t be as dramatic as what stimulants deliver.
This doesn’t mean Strattera is a weak medication. It means it occupies a different tier. For people who can’t tolerate stimulants, have a history of substance use, experience significant anxiety alongside ADHD, or simply prefer a non-controlled medication, Strattera offers a real therapeutic benefit that builds steadily over time.
How Long It Takes to Work
One of the biggest differences between Strattera and stimulants is timing. Stimulants typically produce noticeable effects within an hour of the first dose. Strattera works on a completely different schedule. Some people notice subtle changes within the first week, but the full effect takes 8 to 12 weeks to develop. Some people continue to see increasing benefit for up to 24 weeks or longer.
A pooled analysis of two large adult trials from Johns Hopkins illustrates this well. At one week, the effect size was 0.28, which is small. By four weeks it had grown to 0.45. By 26 weeks it reached 0.52 overall, and in the group taking 80 mg, the effect size climbed to 0.82, which enters the “large” category. The response rate, measured by the percentage of patients achieving at least a 50% reduction in symptoms, continued to rise throughout the entire 26-week study period.
This slow buildup means many people abandon Strattera too early. If you’ve been on it for three or four weeks and feel underwhelmed, the medication may not have reached its full potential yet.
Effectiveness in Children and Teens
The FDA approved Strattera based on four randomized, placebo-controlled studies in patients aged 6 to 18. All four showed statistically significant improvement in ADHD symptoms compared to placebo. The studies ranged from six to nine weeks and measured both inattentive and hyperactive/impulsive symptoms using a standardized rating scale scored by clinicians with parent input.
Dose matters. In one study of nearly 300 children and adolescents, only the two higher dose levels (1.2 and 1.8 mg/kg per day) outperformed placebo. The lower dose did not. This pattern held across studies: the medication needs to reach an adequate dose to work. For children under 70 kg, the target dose is about 1.2 mg/kg per day, starting at 0.5 mg/kg and increasing after at least three days.
Effectiveness in Adults
Adults tend to show a somewhat smaller response to Strattera than children, with an average effect size around 0.45. But the 26-week data is encouraging. Adults who stayed on the medication at the 80 mg dose saw their effect size nearly double compared to the four-week mark, suggesting patience with the medication pays off. The target dose for adults is 80 mg per day, with the option to increase to 100 mg after two to four additional weeks if the response is insufficient.
How Strattera Works Differently
Strattera is not a stimulant. It works by blocking the reuptake of norepinephrine, a brain chemical involved in attention, alertness, and executive function. Stimulants primarily boost dopamine (and norepinephrine to varying degrees), which is why they produce a more immediate and pronounced effect on focus and motivation.
Because of this different mechanism, Strattera has no abuse potential. In a controlled study comparing its subjective effects to placebo, it produced no pattern of euphoria or stimulant-like effects. It is not a controlled substance, which means prescriptions can include refills and don’t require a new paper prescription each month. For people with a history of stimulant misuse, or for parents concerned about diversion in a household with teenagers, this is a practical advantage.
A Strong Option When Anxiety Is Present
Strattera has a notable edge in one specific population: people with both ADHD and anxiety. In a study of 176 children with both conditions, 12 weeks of Strattera produced substantially greater ADHD symptom improvement than placebo, with a mean symptom score change of -10.5 versus -1.4. Importantly, anxiety symptoms improved alongside the ADHD symptoms. Stimulants, by contrast, can sometimes worsen anxiety.
Similar results have been found for ADHD with co-occurring depression. In a controlled trial, patients treated with Strattera showed significant reductions in ADHD symptoms, depressive symptoms, and anxiety symptoms simultaneously. This dual benefit makes Strattera particularly useful when ADHD isn’t the only thing going on.
Common Side Effects
Strattera’s side effect profile differs from stimulants. The most common complaints in adults are dry mouth (21%), nausea (12%), and fatigue or lethargy (7%). In children and teens, nausea occurs in 7 to 12% of patients depending on dosing schedule, with fatigue in 4 to 9% and dry mouth in 1 to 4%. These side effects are generally most noticeable in the first few weeks and often diminish over time.
Notably absent from the common side effects list: the appetite suppression and insomnia that frequently accompany stimulant use. Strattera can be taken in the morning or split into morning and evening doses, and it provides continuous coverage without the “wearing off” crash that some people experience with stimulants in the late afternoon.
Who Benefits Most From Strattera
Strattera is not the most powerful ADHD medication available. If raw symptom control is the only priority and there are no complicating factors, stimulants will outperform it for most people. But effectiveness isn’t just about effect sizes on a rating scale. It’s also about tolerability, consistency, and fit with a person’s broader health picture.
Strattera tends to work best for people who have ADHD alongside anxiety or depression, who have had problematic side effects from stimulants (especially insomnia, appetite loss, or rebound irritability), who need 24-hour coverage without taking multiple doses, or who need a medication without abuse potential. It also works well as an add-on to a stimulant when the stimulant alone isn’t enough, though this is an off-label use. The key is giving it enough time. The medication that seems underwhelming at week three may be working well by week twelve.